Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus

Liang Zhang; Yue Wang; Yi Xiao; Yu Wang; JinKai Dong; Kun Gao; Yan Gao; Xi Wang; Wei Zhang; YuanJi Xu; JinQi Yan; JiYun Yu

doi:10.1371/journal.pone.0090551

Loading metrics

Open Access

Peer-reviewed

Research Article

Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus

Liang Zhang ,

Contributed equally to this work with: Liang Zhang, Yue Wang, Yi Xiao, Yu Wang

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
Yue Wang ,

Contributed equally to this work with: Liang Zhang, Yue Wang, Yi Xiao, Yu Wang

Affiliations Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China, National Center for AIDS/STD Control and Prevention, China-CDC, Beijing, China
⨯
Yi Xiao ,

Contributed equally to this work with: Liang Zhang, Yue Wang, Yi Xiao, Yu Wang

Affiliations Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China, Department of Urology, First Affiliated Hospital of General Hospital of PLA, Beijing, China
⨯
Yu Wang ,

Contributed equally to this work with: Liang Zhang, Yue Wang, Yi Xiao, Yu Wang

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
JinKai Dong,

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
Kun Gao,

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
Yan Gao,

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
Xi Wang,

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
Wei Zhang,

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
YuanJi Xu,

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
JinQi Yan,

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯
JiYun Yu

* E-mail: yujyun@126.com

Affiliation Beijing Institute of Basic Medical Sciences, Haidian district, Beijing, China
⨯

Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus

Liang Zhang,
Yue Wang,
Yi Xiao,
Yu Wang,
JinKai Dong,
Kun Gao,
Yan Gao,
Xi Wang,
Wei Zhang,
YuanJi Xu

Published: March 7, 2014
https://doi.org/10.1371/journal.pone.0090551

Reader Comments

Post a new comment on this article

About co-corresponding authors

Posted by yujiyun on 18 May 2014 at 02:41 GMT

Jinqi Yan and Jiyun Yu have conceived and designed this experiments, at the same time, they are also
project investigator of this study. So they are all corresponding authors of this paper and their E-mail address are yanjinqi@sohu.com and yujyun@126.com respectively.

No competing interests declared.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
DNA vaccination
Is the Subject Area "DNA vaccination" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Recombinant vaccines
Is the Subject Area "Recombinant vaccines" applicable to this article?

Thanks for your feedback.

Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus

Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus

Reader Comments

Post Your Discussion Comment

Why should this posting be reviewed?

Thank You!

About co-corresponding authors

Posted by yujiyun on 18 May 2014 at 02:41 GMT